source
- Vivodyne’s Human Tissue Factory Wins Endpoints 11 2026, Promising Faster Drug TestingVivodyne was announced as the winner of the Endpoints 11 2026 competition for its human tissue factory technology. The platform creates human tissue constructs that can be used in preclinical drug…
- Lundbeck plans US headquarters move to Boston to boost neuroscience R&DLundbeck, a Danish pharmaceutical company focused on neuroscience, announced it will relocate its U.S. operations to Boston. The move is part of a broader strategy to concentrate R&D on increasing…